Teleoncology or telemedicine for oncology patients during the COVID-19 pandemic: the new normal for breast cancer survivors?
Future Oncol
; 16(28): 2191-2195, 2020 Oct.
Article
in English
| MEDLINE | ID: covidwho-732936
ABSTRACT
Background:
Telemedicine is seen as a savior during the COVID-19 pandemic. Materials &methods:
This study is a descriptive cross-sectional study conducted with cancer patients who were interviewed via telemedicine from a tertiary care comprehensive oncology center.Results:
A total of 421 patients were included in the study and 118 of them (28.0%) were >65 years old. Communication was provided most frequently by voice call (n = 213; 50.5%). The majority of the patients contacted by telemedicine had breast cancer (n = 270; 64.1%). For 135 patients (32.1%) no further examination or intervention was required and the previously planned follow-up visit was postponed by the clinician.Conclusion:
This study showed that telemedicine could open a new era for medical oncology specialists.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Breast Neoplasms
/
Telemedicine
/
Coronavirus Infections
/
Pandemics
/
Cancer Survivors
/
Medical Oncology
Type of study:
Cohort study
/
Diagnostic study
/
Observational study
/
Prognostic study
/
Randomized controlled trials
Topics:
Long Covid
Language:
English
Journal:
Future Oncol
Year:
2020
Document Type:
Article
Affiliation country:
Fon-2020-0714
Similar
MEDLINE
...
LILACS
LIS